Valuation stops being abstract the moment you receive a letter of intent, start fielding acquisition calls, or begin planning your exit. That number on paper becomes a real decision with real consequences. And for most healthcare owners, it comes with a jarring surprise: the buyer’s number and the seller’s number don’t match, sometimes by a wide margin.
That gap rarely reflects bad faith. It usually reflects something more basic. Different buyers use different valuation methods, and each method tells a different story about what your practice is worth. Understanding those three methods, SDE, EBITDA, and strategic value, before you enter a transaction is one of the clearest advantages you can give yourself.
Why Healthcare Valuations Are More Complicated Than Most Industries
Healthcare businesses operate under constraints most industries never encounter. Regulatory requirements, reimbursement structures, corporate practice of medicine laws, and licensing restrictions all affect how a business can be owned, operated, and transferred. Those factors don’t only shape day-to-day operations. They shape valuation methodology, too.
Buyer type plays an equally significant role. A private equity group approaching your practice thinks differently than a DSO, a regional health system, or an individual physician buyer. Each brings different return expectations, financing structures, and frameworks for determining your business value. That’s precisely why healthcare valuation discrepancies between what owners expect and what buyers offer are so common and so disorienting when you haven’t prepared for them.
What SDE Measures, and When It Applies to Your Practice
Seller’s Discretionary Earnings adds the owner’s total compensation, salary, benefits, and personal expenses run through the business, back to net profit. The result is a single number that reflects the full economic benefit the business provides to a single working owner. For owner-operated practices, single-location clinics, and smaller revenue businesses, SDE is typically the right starting point.
The critical word is “to you.” SDE reflects what the business is worth to an owner who works inside it. Common add-backs in healthcare include personal vehicle expenses, above-market owner compensation, personal health insurance, and other owner-specific costs. When a buyer plans to step into your role or hire a replacement at market salary, those add-backs don’t transfer. That’s where the first valuation gap often appears, and why valuation methodology in a healthcare business transaction matters so early in the process.
What EBITDA Measures, and When Buyers Shift to It
EBITDA, which stands for earnings before interest, taxes, depreciation, and amortization, strips out financing decisions and non-cash charges to show the underlying operating earnings of the business. Institutional buyers, private equity groups, DSOs, and health systems default to EBITDA because it allows cleaner comparisons across acquisitions and supports deal structuring that SDE doesn’t accommodate well.
The shift typically happens when a practice crosses a certain revenue or earnings threshold, often around $1 million to $2 million in annual earnings, though this varies by specialty and buyer type. Adjusted EBITDA goes further by normalizing one-time expenses, adjusting owner compensation to market rates, and accounting for other non-recurring items. In healthcare deals, that normalization process matters more than most owners expect. A practice showing $500,000 in EBITDA before adjustments might show $750,000 or more after a disciplined review, and that difference compounds when multiplied by an acquisition multiple.
Strategic Value: The Third Number No Formula Fully Captures
Strategic value is what a specific buyer will pay because of what your business means to its broader plan, not simply what the financials show. In healthcare M&A, several factors drive premium offers beyond the income statement: geographic market position, patient volume and retention, payer mix quality, provider talent, and the difficulty of replicating your footprint organically.
The distinction between platform and add-on acquisitions is worth understanding here. A buyer building a platform in your market may pay a meaningful premium because your practice anchors their regional strategy. That same practice sold to a buyer already established in your area might transact at a lower multiple because the strategic fit is weaker. Strategic value in healthcare M&A can produce offers that significantly exceed what an EBITDA-based formula would suggest, but only when the right buyer sees the right opportunity at the right time.
How the Same Practice Can Produce Three Different Valuations
Consider a primary care practice generating $400,000 in owner earnings. An individual buyer using SDE might apply a 2.5x multiple, arriving at a $1 million valuation. A PE-backed group using adjusted EBITDA at a 5x multiple, after normalizing owner compensation to market rate, might land at $1.5 million. A health system looking to anchor a new market might see that same practice as worth $2 million or more based on strategic positioning alone.
Same practice, same financials, three materially different numbers. The risk of anchoring to a single evaluation before understanding how your buyer pool thinks is real. You might walk away from a fair offer believing it was low, or accept one without knowing a better option was available. Healthcare valuation discrepancies like this are common. They’re also avoidable with the right preparation.
What You Should Know Before Entering a Transaction
The first question to answer before going to market is which metric your most likely buyers will use. A practice that attracts PE interest should be prepared with clean EBITDA documentation and a defensible normalization schedule. A practice more likely to sell to an individual or smaller group buyer should have SDE clearly articulated. Knowing your buyer pool shapes how you present your financials from the start.
Financial normalization, timing, and documentation are not things you address at the deal table. They’re pre-transaction priorities. Cleaning up non-recurring expenses, correcting owner compensation to market rate, and organizing supporting documentation before you go to market give you control over the number you’re defending. A qualified advisor helps you reconcile differences in methodology before a buyer frames the conversation entirely on their terms.
FAQs
Should I use SDE or EBITDA to value my healthcare practice?
Use SDE if you’re an owner-operated or single-location practice with smaller revenue; shift to EBITDA once earnings cross roughly $1 million to $2 million or when institutional buyers like PE groups and DSOs enter the picture.
Why does the same practice get such different valuations from different buyers?
Each buyer type applies a different methodology and multiple: individual buyers use SDE, PE groups and DSOs use adjusted EBITDA, and strategic buyers price in market positioning that no formula fully captures.
What are common EBITDA add-backs in a healthcare practice sale?
Above-market owner compensation, personal vehicle expenses, owner health insurance, and other non-recurring or owner-specific costs, all of which must be documented and defensible before due diligence begins.
Know Your Number Before Buyers Define It
A healthcare valuation is only useful if it reflects how real buyers will evaluate your practice. SDE, EBITDA, and strategic value can point to very different outcomes, and the wrong framing can weaken your position before negotiations begin. Before you enter the market, clarify your buyer pool, normalize your financials, and understand which valuation story gives you the strongest footing with Inflection 360’s Strategic Alternatives and Exit Strategy Development.
